No mandated tech stack

Auxo Medical Franchising

Health services

Software purchasing authority at Auxo Medical Franchising is not publicly documented in the 2023 FDD, and no HQ executives are on file. The brand mandates no specific technology stack according to available data. With only 1 franchised unit and 3 company-owned locations, the addressable market is extremely small.

Live signals

Total units
4
1 franchised
Unit growth YoY
vs prior filing
AUV
Item 19, 2023
Royalty
8%
of gross sales
Ad fund
2%
national + local
Initial fee
$50K
per unit
Investment range
$100K–$138K
all-in, Item 7
Procurement
Approved supplier
from the filing

The vendor opportunity at Auxo Medical Franchising

Auxo Medical Franchising operates in the health-services sector with headquarters in Virginia. According to the 2023 Franchise Disclosure Document, the system consists of only 4 total units—3 company-owned and 1 franchised location. For a software vendor, the immediate addressable market is that single franchised unit, as company-owned locations typically follow a separate purchasing path. No year-over-year unit growth rate is disclosed, and average unit volume (AUV) is not reported in the available data. The royalty rate stands at 8.0% of gross revenue, with an initial franchise term of 10 years. This is a nascent or tightly held system, meaning any vendor engagement will be highly account-specific rather than scalable across a large franchise network.

Who controls software purchasing

The 2023 FDD does not name any HQ executives, and no decision-maker profiles are on file. Without a disclosed leadership structure or technology committee, vendors cannot assume a centralized purchasing model. In systems this small, the founder or a single operations lead often controls all vendor selection, but that remains unconfirmed here. If you are selling software, your first step is direct discovery: identify who manages operations for the one franchised location and whether that person also influences the company-owned units. Expect a relationship-driven sale rather than a formal RFP process.

Mandated and current tech stack

No mandated or recommended technology is captured in the FDD data for Auxo Medical Franchising. This absence suggests either an open technology environment or simply that the franchisor has not formalized IT requirements in its disclosure. For vendors, this is a blank-slate scenario: the franchisee may be using off-the-shelf tools or nothing at all in categories like POS, scheduling, or compliance. Your pitch should emphasize ease of adoption and direct operational ROI, since there is no incumbent stack to displace and no franchisor mandate to satisfy.

Procurement, renewals, and timing

The FDD extract does not include an Item 8 procurement signal, so the purchasing model—whether designated supplier, approved supplier, or fully open—is unknown. Renewal terms are clearer: a franchisee must be in compliance, provide 180 days’ written notice, sign the then-current franchise agreement, and obtain a personal guarantee from the owners. The renewal term is 5 years, which is shorter than the initial 10-year term. This structure creates a potential trigger point for software evaluation around the renewal window, but with only one franchised unit, the timeline is singular rather than a rolling portfolio of expirations. Vendors should monitor that unit’s original signing date to anticipate when a renewal—and possible tech refresh—might occur.

How to read the Auxo Medical Franchising FDD

The full 2023 FDD is embedded below for your review. Focus on Item 8 (if present in the complete document) to confirm any purchasing restrictions, and Item 11 for any franchisor obligations around technology that may not have been captured in the summary data. Given the small unit count, the FDD may be relatively brief, but it remains the definitive source for understanding the legal and operational constraints that would affect a software sale. For a ranked target list of franchise systems that match your ideal customer profile, FranCloud can help you prioritize opportunities beyond this single-unit system.

Questions vendors ask

Auxo Medical Franchising, answered from the filing

The 2023 FDD does not identify specific decision-makers or a buying center. No HQ executives are on file, so the purchasing authority structure remains unknown to outside vendors.
No mandated or recommended technology is captured in the available FDD data. Vendors should assume an open or unspecified tech environment until confirmed directly with the franchisor.
The system totals 4 units: 3 company-owned and 1 franchised location. This is a very small health-services franchise based in Virginia.
The procurement model is not disclosed in the available FDD extract. It is unclear whether the franchisor designates suppliers, maintains an approved list, or allows open purchasing.
Initial franchise terms run 10 years, with 5-year renewals available if compliant. With only 1 franchised unit and no recent growth data, predictable contract windows are not evident.
The 2023 FDD was filed with state franchise regulators. You can review the embedded PDF viewer below to examine the full disclosure document directly.
Source

Read the filing itself

Every number on this page traces back to this document. Read it in full, page by page — downloading the original PDF is a paid feature.

Auxo Medical Franchising2023 FDDView only

View only The original PDF download is included with any FranCloud plan.

FDD alert

Tell me when this brand refiles.

We’ll email you the moment Auxo Medical Franchising files a new annual FDD — usually the freshest signal of a vendor change.

Sell software to franchises? See the playbook.

Your matched accounts, fit-scored to what you sell, with the contacts and openers built from each filing.

Find my accounts

Related Health services brands

Primary franchise filings · updated June 2026. Every figure is source-traceable and QA-checked.